Elite Pharmaceuticals Market Cap

Elite Pharmaceuticals has a market cap or net worth of $416.87 million as of March 13, 2026. Its market cap has decreased by -20.20% in one year.

Market Cap

416.87M

Enterprise Value

401.83M

Revenue

140.12M

Ranking

n/a

PE Ratio

10.87

Stock Price

$0.39

Market Cap Chart

Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 416.87M, an increase of 4,253.60%. That is a compound annual growth rate of 14.62%.

Market Cap History

Date	Market Cap	% Change
Mar 12, 2026	418.35M	-20.58%
Dec 31, 2025	526.74M	-8.88%
Dec 31, 2024	578.04M	306.60%
Dec 29, 2023	142.16M	374.74%
Dec 30, 2022	29.95M	-10.40%
Dec 31, 2021	33.42M	-36.49%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Nika Pharmaceuticals	791.42M
Glass House Brands	640.36M
Jushi Holdings	93.46M
Growth Stalk Holdings	89.31M
Sofgen Pharma	55.75M
Healthy Extracts	39.65M
Earth Science Tech	34.42M
Radnostix	32.01M

Market Cap Rankings